These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38115859)

  • 21. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
    Sánchez-Busó L; Cole MJ; Spiteri G; Day M; Jacobsson S; Golparian D; Sajedi N; Yeats CA; Abudahab K; Underwood A; Bluemel B; Aanensen DM; Unemo M;
    Lancet Microbe; 2022 Jun; 3(6):e452-e463. PubMed ID: 35659907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
    Kakooza F; Golparian D; Matoga M; Maseko V; Lamorde M; Krysiak R; Manabe YC; Chen JS; Kularatne R; Jacobsson S; Godreuil S; Hoffman I; Bercot B; Wi T; Unemo M
    J Antimicrob Chemother; 2023 Aug; 78(8):1982-1991. PubMed ID: 37352017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016.
    George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo YR; Ishikawa N; Wi T; Lahra MM
    PLoS One; 2019; 14(4):e0213312. PubMed ID: 30943199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility surveillance and antimicrobial resistance in
    Kakooza F; Kiggundu R; Mboowa G; Kateete PD; Nsangi OT; Kabahita JM; Ssentalo Bagaya B; Golparian D; Unemo M
    Front Microbiol; 2023; 14():1148817. PubMed ID: 37089569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
    Workneh M; Hamill MM; Kakooza F; Mande E; Wagner J; Mbabazi O; Mugasha R; Kajumbula H; Walwema R; Zenilman J; Musinguzi P; Kyambadde P; Lamorde M; Manabe YC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17009. PubMed ID: 32519969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16.
    Lan PT; Golparian D; Ringlander J; Van Hung L; Van Thuong N; Unemo M
    J Antimicrob Chemother; 2020 Jun; 75(6):1432-1438. PubMed ID: 32068837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates from Ukraine, 2013-2018.
    Boiko I; Golparian D; Jacobsson S; Krynytska I; Frankenberg A; Shevchenko T; Unemo M
    APMIS; 2020 Jul; 128(7):465-475. PubMed ID: 32441045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
    Riou J; Althaus CL; Allen H; Cole MJ; Grad YH; Heijne JCM; Unemo M; Low N
    BMC Infect Dis; 2023 Apr; 23(1):252. PubMed ID: 37081443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013.
    Lebedzeu F; Golparian D; Titov L; Pankratava N; Glazkova S; Shimanskaya I; Charniakova N; Lukyanau A; Domeika M; Unemo M
    BMC Infect Dis; 2015 Jan; 15():29. PubMed ID: 25637258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts.
    Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JR; Ramon-Pardo P; Bolan G; Wi T
    Sex Health; 2019 Sep; 16(5):412-425. PubMed ID: 31437420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.
    Mlynarczyk-Bonikowska B; Serwin AB; Golparian D; Walter de Walthoffen S; Majewski S; Koper M; Malejczyk M; Domeika M; Unemo M
    BMC Infect Dis; 2014 Feb; 14():65. PubMed ID: 24502606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National surveillance of
    Machado HM; Martins JM; Schörner MA; Gaspar PC; Bigolin A; Ramos MC; Ferreira WA; Pereira GFM; Miranda AE; Unemo M; Bazzo ML;
    JAC Antimicrob Resist; 2022 Aug; 4(4):dlac076. PubMed ID: 35795244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance in
    Hernando Rovirola C; Spiteri G; Sabidó M; Montoliu A; Gonzalez V; Casabona J; Cole MJ; Noori T; Unemo M
    Sex Transm Infect; 2020 May; 96(3):204-210. PubMed ID: 32019895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of
    Blouin K; Lefebvre B; Trudelle A; Defay F; Perrault Sullivan G; Ezin Aloffan LND; Labbé AC
    BMJ Open; 2023 Aug; 13(8):e073849. PubMed ID: 37541749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
    Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
    BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.
    Cole MJ; Spiteri G; Town K; Unemo M; Hoffmann S; Chisholm SA; Amato-Gauci AJ; van de Laar M; Ison CA;
    Sex Transm Dis; 2014 Dec; 41(12):723-9. PubMed ID: 25581808
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014-2017.
    Yéo A; Kouamé-Blavo B; Kouamé CE; Ouattara A; Yao AC; Gbedé BD; Bazan F; Faye-Ketté H; Dosso M; Wi T; Unemo M
    Sex Transm Dis; 2019 Mar; 46(3):179-184. PubMed ID: 30461598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.